NanoViricides, Inc. - Product Pipeline Review - 2015

Published: October 2015
No. of Pages: 40
   

Global Markets Direct’s, ‘NanoViricides, Inc. Product Pipeline Review 2015’, provides an overview of the NanoViricides, Inc.’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of NanoViricides, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope


  • The report provides brief overview of NanoViricides, Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of NanoViricides, Inc.’s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the NanoViricides, Inc.’s pipeline products

Reasons to buy


  • Evaluate NanoViricides, Inc.’s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of NanoViricides, Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the NanoViricides, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of NanoViricides, Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of NanoViricides, Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope
  • Explore the dormant and discontinued projects of NanoViricides, Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

NanoViricides, Inc. - Product Pipeline Review - 2015

Table of Contents

Table of Contents 2
List of Tables 4
List of Figures 4
NanoViricides, Inc. Snapshot 5
NanoViricides, Inc. Overview 5
Key Information 5
Key Facts 5
NanoViricides, Inc. - Research and Development Overview 6
Key Therapeutic Areas 6
NanoViricides, Inc. - Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products - Monotherapy 10
NanoViricides, Inc. - Pipeline Products Glance 11
NanoViricides, Inc. - Early Stage Pipeline Products 11
Preclinical Products/Combination Treatment Modalities 11
Discovery Products/Combination Treatment Modalities 12
NanoViricides, Inc. - Drug Profiles 13
DengueCide 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
EKCCide-I 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
Herpecide 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
HIVCide-I 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
NVINF-1 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
NVINF-2 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
RabiCide-I 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
Small molecule for Ebola and Marburg Infections 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
ADIFBase-I 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
HIVCide-II 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
Small Molecule for Middle East Respiratory Syndrome Human Coronavirus Infection 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
NanoViricides, Inc. - Pipeline Analysis 26
NanoViricides, Inc. - Pipeline Products by Target 26
NanoViricides, Inc. - Pipeline Products by Route of Administration 27
NanoViricides, Inc. - Pipeline Products by Molecule Type 28
NanoViricides, Inc. - Pipeline Products by Mechanism of Action 29
NanoViricides, Inc. - Recent Pipeline Updates 30
NanoViricides, Inc. - Dormant Projects 36
NanoViricides, Inc. - Discontinued Pipeline Products 37
Discontinued Pipeline Product Profiles 37
AviFluCide-I 37
FluCideHP-I 37
NanoViricides, Inc. - Locations And Subsidiaries 38
Head Office 38
Appendix 39
Methodology 39
Coverage 39
Secondary Research 39
Primary Research 39
Expert Panel Validation 39
Contact Us 39
Disclaimer 40

List of Tables

NanoViricides, Inc., Key Information 5
NanoViricides, Inc., Key Facts 5
NanoViricides, Inc. - Pipeline by Indication, 2015 7
NanoViricides, Inc. - Pipeline by Stage of Development, 2015 9
NanoViricides, Inc. - Monotherapy Products in Pipeline, 2015 10
NanoViricides, Inc. - Preclinical, 2015 11
NanoViricides, Inc. - Discovery, 2015 12
NanoViricides, Inc. - Pipeline by Target, 2015 26
NanoViricides, Inc. - Pipeline by Route of Administration, 2015 27
NanoViricides, Inc. - Pipeline by Molecule Type, 2015 28
NanoViricides, Inc. - Pipeline Products by Mechanism of Action, 2015 29
NanoViricides, Inc. - Recent Pipeline Updates, 2015 30
NanoViricides, Inc. - Dormant Developmental Projects,2015 36
NanoViricides, Inc. - Discontinued Pipeline Products, 2015 37

List of Figures

NanoViricides, Inc. - Pipeline by Top 10 Indication, 2015 7
NanoViricides, Inc. - Pipeline by Stage of Development, 2015 9
NanoViricides, Inc. - Monotherapy Products in Pipeline, 2015 10
NanoViricides, Inc. - Pipeline by Top 10 Target, 2015 26
NanoViricides, Inc. - Pipeline by Top 10 Route of Administration, 2015 27
NanoViricides, Inc. - Pipeline by Top 10 Molecule Type, 2015 28
NanoViricides, Inc. - Pipeline Products by Top 10 Mechanism of Action, 2015 29

Published By: Global Markets Direct
Product Code: Global Markets Direct13274


Did you find what you are/were looking for ? If not, read below and browse through other relevant pages for similar market research reports OR get in touch with us through the form/contact info in your right navigation panel and we�ll share relevant market report titles for you to explore.

Related Reports:


Why ReportsnReports.com?

  • 500,000 market research reports and growing.
  • Top Fortune 500 Organizations trust us for research data.
  • 24/7 support on call as well as emails.
  • Your Details are safe with us.
  • Free support for your research requirements.
  • Report Delivery: Email
  • Delivery Time:
    • Upto 24 hrs - working days
    • Upto 48 hrs max - weekends and public holidays

Research Support / Custom Research

If this business study does not have the data and information analysis you need, contact us with your research requirements. We explore available market research reports to map your needs and share report titles with you. Alternatively, we can also offer custom research that suits your budget and timelines. Share your information requirements here.
Connect With Us
Email: sales@reportsandreports.com Call : + 1 888 391 5441

Subscription Option

Using our subscription option, you get access to market research reports and industry data of Biotechnology market as per your needs. Get the best of Biotechnology research reports by utilizing your research budgets in an optimum way.

More about our Subscription option
Email Alerts

Get Email alerts about market research reports from industries and publishers of your interest: